Immunization After Invasive Haemophilus influenzae Type b Disease
- 1 January 1989
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Diseases of Children
- Vol. 143 (1) , 31-33
- https://doi.org/10.1001/archpedi.1989.02150130041012
Abstract
• Fifteen children with previous invasiveHaemophilus influenzaetype b disease were immunized with aHemophilus-diphtheria toxin mutant protein conjugate vaccine. Serologic responses were compared with those of 31 newly immunized children without previous invasiveH influenzaetype b disease. Mean levels of antibody to polyribosylribitol phosphate among study children younger than 18 months were 0.086 mg/L before immunization, 0.737 mg/L after first immunization, and 4.453 mg/L after second immunization. In contrast, the comparable mean polyribosylribitol phosphate antibody levels among control children younger than 18 months were 0.107, 3.580, and 63.502 mg/L. A similar pattern of results was found among children aged 18 months or older. Although children with previous invasiveH influenzaetype b disease do not respond as vigorously to conjugate vaccine as do previously healthy controls, the response is sufficient to justify routine immunization of such children. (AJDC1989;143:31-33)This publication has 12 references indexed in Scilit:
- Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in InfancyNew England Journal of Medicine, 1987
- Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein conjugate vaccineThe Journal of Pediatrics, 1987
- IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEINThe Lancet, 1986
- Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type bThe Journal of Pediatrics, 1985
- Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197.Journal of Clinical Investigation, 1985
- Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of ageThe Journal of Pediatrics, 1985
- Prevention ofHemophilus influenzaeType B Bacteremic Infections with the Capsular Polysaccharide VaccineNew England Journal of Medicine, 1984
- Outer membrane protein subtypes and investigation of recurrent Haemophilus influenzae type b diseaseThe Journal of Pediatrics, 1982
- Intrinsic Tritium Labeling of the Capsular Polysaccharide Antigen of Haemophilus Influenzae Type BThe Journal of Immunology, 1978
- Serologic Responses of Children with Meningitis Due to Haemophilus influenzae Type bThe Journal of Infectious Diseases, 1976